September 1st 2025
The research, published in JAMA Health Forum, examined 950 AIMDs approved by the US Food and Drug Administration as of November 2024.
AI used to advance drug delivery system for glaucoma and other chronic diseases
June 2nd 2023The project, a collaboration with researchers from the University of Maryland, holds promise for advancing new and more tolerable drug treatments for common chronic blinding eye diseases, including glaucoma and macular degeneration.
ASCRS 2023: Predicting vision outcomes in cataract surgery with machine learning
Mark Packer, MD, sat down with Sheryl Stevenson, Group Editorial Director, Ophthalmology Times®, to discuss his presentation on machine learning and predicting vision outcomes after cataract surgery at the ASCRS annual meeting in San Diego.
Case report: OCT in the detection and diagnosis of neurofibromatosis type 1
April 18th 2023Neurofibromatosis type 1 (NF1) is a condition associated with significant systemic morbidity. Abnormal proliferation of cells derived from the neural crest can cause benign and malignant tumors throughout the body in NF1.